[Abstract Only] Observational Study Suggests Apixaban May Be a Better Choice than Rivaroxaban for Patients with Atrial Fibrillation
11 Mar, 2020 | 08:20h | UTCEffectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban – TCTMD (free)